Sonoma Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Sonoma Pharmaceuticals Inc.
- Former names
- Oculus Innovative Sciences, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boulder
- Headquarters state / province
- Colorado
- Headquarters country
- United States
- Fiscal year end
- March
- Ticker symbol
- SNOA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001367083
- EIN
- 68-0423298
Board of directors
-
Jay E. Birnbaum · DirectorSince 2025
-
John Mclaughlin · DirectorSince 2025
-
Philippe Weigerstorfer · DirectorSince 2025
-
Vanessa Jacoby · DirectorSince 2026
Director election results
Annual meeting of September 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 20, 2024 | Trombly Amy Moss Officer (Chief Executive Officer) | Grant or award | +53,586 | — | — |
| Jun 20, 2024 | Thornton Bruce Officer (Executive Vice President) | Grant or award | +53,586 | — | — |
| Jun 20, 2024 | DVONCH JEROME J Officer (Chief Financial Officer) | Grant or award | +53,586 | — | — |
| Jun 20, 2024 | Dal Poggetto John Officer (Controller) | Grant or award | +15,000 | — | — |
| Jun 30, 2023 | Trombly Amy Moss Officer (Chief Executive Officer) | Grant or award | +100,000 | — | — |
| Jun 30, 2023 | Thornton Bruce Officer (Executive Vice President) | Grant or award | +100,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.